Project Description

Camras Vision is an ophthalmic medical device company developing a patented new technology for the 67 million glaucoma sufferers that will provide the first-ever personalized treatment to prevent blindness. Ophthalmologists are faced with limited surgical treatments due to their instability and unpredictability in controlling glaucoma.

As a result, 1 out of 10 patients still lose their vision even when properly treated. Camras Vision wishes to address these problems with their device, the Camras Shunt.